Correction: Capsaicin treatment attenuates cholangiocarcinoma carcinogenesis (PLoS ONE (2014) 9:4 (e95605) DOI: 10.1371/journal.pone.0095605);Capsaicin treatment attenuates cholangiocarcinoma carcinogenesis

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Wutka, Annika ^a   Palagani, Vindhya ^a   Barat, Samarpita ^a   Chen, Xi ^a   El Khatib, Mona ^a   Götze, Julian ^a   Belahmer, Hanane ^a   Zender, Steffen ^b   Bozko, Przemyslaw ^a   Malek, Nisar P ^a   Plentz, Ruben R ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b Hepatology and Endocrinology ^*  (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSAICIN; SONIC HEDGEHOG PROTEIN;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BILE DUCT CARCINOMA; CANCER PROGNOSIS; CARCINOGENESIS; CARCINOMA CELL; CELL GROWTH; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; APOPTOSIS; BILE DUCT TUMOR; CELL MOTION; CELL SURVIVAL; CELL TRANSFORMATION; DRUG EFFECTS; DRUG SCREENING; INTRAHEPATIC BILE DUCT; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

APOPTOSIS; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CAPSAICIN; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; CELL TRANSFORMATION, NEOPLASTIC; CHOLANGIOCARCINOMA; EPITHELIAL-MESENCHYMAL TRANSITION; HEDGEHOG PROTEINS; HUMANS; SIGNAL TRANSDUCTION; TUMOR STEM CELL ASSAY;

EID: 84899688700     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0162673     Document Type: Erratum

References (58)

1. von Hahn T, Ciesek S, Wegener G, Plentz RR, Weismuller TJ, et al. (2011) Epidemiological trends in incidence and mortality of hepatobiliary cancers in Germany. Scand J Gastroenterol 46: 1092-1098.
2. Shaib Y, El-Serag HB (2004) The epidemiology of cholangiocarcinoma. Semin Liver Dis 24: 115-125. (Pubitemid 38738341)
3. Carriaga MT, Henson DE (1995) Liver, gallbladder, extrahepatic bile ducts, and pancreas. Cancer 75: 171-190.
4. Gatto M and Alvaro D (2010) New insights on cholangiocarcinoma. World J Gastrointest Oncol 15: 36-145.
5. Welzel TM, McGlynn KA, Hsing AW, O'Brien TR, Pfeiffer RM (2006) Impact of classification of hilar cholangiocarcinomas (Klatskin tumors) on the incidence of intra- and extrahepatic cholangiocarcinoma in the United States. J Natl Cancer Inst 98: 873-875. (Pubitemid 43923444)
6. Claessen MM, Vleggaar FP, Tytgat KM, Siersema PD, van Buuren HR (2009) High lifetime risk of cancer in primary sclerosing cholangitis. J Hepatol 50: 158-64
7. Tyson GL, El-Serag HB (2011) Risk factors for cholangiocarcinoma. Hepatology 54: 173-84.
8. Khan SA, Taylor-Robinson SD, Davidson BR, Taylor-Robinson SD (2005) Cholangiocarcinoma: seminar. Lancet 366: 1303-14.
9. Kiesslich T, Wolkersdorfer G, Neureiter D, Salmhofer H, Berr F (2009) Photodynamic therapy for non-resectable perihilar cholangiocarcinoma. Photochem Photobiol Sci 8: 23-30.
10. Falkson G, MacIntyre JM, Moertel CG (1984) Eastern Cooperative Oncology Group experience with chemotherapy for inoperable gallbladder and bile duct cancer. Cancer 54: 965-969. (Pubitemid 14069807)
11. Khan S, Davidson BR, Goldin RD, Heaton N, Karani J, et al. (2012) Guidelines for the diagnosis and treatment of cholangiocarcinoma: an update. GUT doi:10.1136/gutjnl-2011-301748
12. Tannapfel A, Benicke M, Katalinic A, Uhlmann D, Kockerling F, et al. (2000) Frequency of p16(INK4A) alterations and K-ras mutations in intrahepatic cholangiocarcinoma of the liver. Gut 47: 721-727.
13. Tannapfel A, Sommerer F, Benicke M, Katalinic A, Uhlmann D, et al. (2003) Mutations of the BRAF gene in cholangiocarcinoma but not in hepatocellular carcinoma. Gut 52: 706-712. (Pubitemid 36528874)
14. Deshpande V, Nduaguba A, Zimmerman SM, Kehoe SM, Macconaill LE, et al. (2011) Mutational profiling reveals PIK3CA mutations in gallbladder carcinoma. BMC Cancer 11: 60.
15. Hezel AF, Deshpande V, Zhu AX (2010) Genetics of biliary tract cancers and emerging targeted therapies. J Clin Oncol 28: 3531-40.
16. Tannapfel A, Weinans L, Geissler F, Schutz A, Katalinic A, et al. (2000) Mutations of p53 tumor suppressor gene, apoptosis, and proliferation in intrahepatic cholangiocellular carcinoma of the liver. Dig Dis Sci 45: 317-324. (Pubitemid 30133893)
17. Khan SA, Thomas HC, Toledano MB, Cox IJ, Taylor-Robinson SD (2005) p53 mutations in human cholangiocarcinoma: a review. Liver Int 25: 704-16. (Pubitemid 41038651)
18. Thongprasert S, Napapan S, Charoentum C, Moonprakan S (2005) Phase II study of gemcitabine and cisplatin as first-line chemotherapy in inoperable biliary tract carcinoma. Ann Oncol 16: 279-281. (Pubitemid 40309310)
19. Lee GW, Kang JH, Kim HG, Lee JS, Jang JS (2006) Combination chemotherapy with gemcitabine and cisplatin as first-line treatment for immunohistoch emically proven cholangiocarcinoma. Am J Clin Oncol 29: 127-131. (Pubitemid 44270949)
20. Tripathi YB, Tripathi P, Arjmandi BH (2005). Nutraceuticals and cancer management. Front Biosci 10: 1607-18. (Pubitemid 40532952)
21. Holzer P (1991). Capsaicin: cellular targets, mechanisms of action, and selectivity for thin sensory neurons. Pharmacol Rev 43(2): 143-201.
22. Govindarajan VS, Sathyanarayana MN (1991). Capsicum-production, technology, chemistry, and quality. Part V. Impact on physiology, pharmacology, nutrition, and metabolism; structure, pungency, pain, and desensitization sequences. Crit Rev Food Sci Nutr 29:435-474.
23. Szallasi A, Blumberg PM (1999). Vanilloid (capsaicin) receptors and mechanisms. Pharmacol Rev 51:159-212.
24. Sancho R, Lucena C, Macho A, Calzado MA, Blanco-Molina M, et al. (2002). Immunosuppressive activity of capsaicinoids: capsiate derived from sweet peppers inhibits NF-kappaB activation and is a potent antiinflammatory compound in vivo. Eur J Immunol 32:1753-1763. (Pubitemid 34679163)
25. Berger A, Henderson M, Nadoolman W, Duffy V, Cooper D, et al. (1995). Oral capsaicin provides temporary relief for oral mucositis pain secondary to chemotherapy-radiation therapy. J Pain Symptom Manage 10:243-248.
26. Hayman M, Kam PCA (2008). Capsaicin: a review of its pharmacology and clinical applications. Curr Anest Crit Care 19:338-343.
27. Wu CC, Lin JP, Yang JS, Chou ST, Chen SC, et al. (2006) Capsaicin induced cell cycle arrest and apoptosis in human esophagus epidermoid carcinoma CE 81 T/VGH cells through the elevation of intracellular reactive oxygen species and Ca2+ productions and caspase- 3 activation. Mutat Res 601:71-82.
28. Kim JD, Kim JM, Pyo JO, Kim SY, Kim BS, et al. (1997) Capsaicin can alter the expression of tumor forming-related genes which might be followed by induction of apoptosis of a Korean stomach cancer cell line, SNU-1. Cancer Lett 120:235-241.
29. Zhang R, Humphreys I, Sahu RP, Shi Y, Srivastava SK (2008). In vitro and in vivo induction of apoptosis by capsaicin in pancreatic cancer cells is mediated through ROS generation and mitochondrial death pathway. Apoptosis 13:1465-1478.
30. Pramanik KC, Boreddy SR, Srivastava SK (2011). Role of mitochondrial electron transport chain complexes in capsaicin mediated oxidative stress leading to apoptosis in pancreatic cancer cells. PLoS One 6:e20151.
31. Jung MY, Kang HJ, Moon A (2001). Capsaicin-induced apoptosis in SK-Hep-1 hepatocarcinoma cells involves Bcl-2 downregulation and caspase-3 activation. Cancer Lett 165:139-145.
32. Huang SP, Chen JC, Wu CC, Chen CT, Tang NY, et al. (2009). Capsaicin-induced apoptosis in human hepatoma HepG2 cells. Anticancer Res 29:165-174.
33. Kim CS, Park WH, Park JY, Kang JH, Kim MO, et al. (2004). Capsaicin, a spicy component of hot pepper, induces apoptosis by activation of the peroxisome proliferator-activated receptor gamma in HT-29 human colon cancer cells. J Med Food 7:267-273.
34. Lu HF, Chen YL, Yang JS, Yang YY, Liu JY, et al. (2010). Antitumor activity of capsaicin on human colon cancer cells in vitro and Colo 205 tumor xenografts in vivo. J Agric Food Chem 58:12999-13005.
35. Brown KC, Witte TR, Hardman WE, Luo H, Chen YC, et al. (2010). Capsaicin displays anti-proliferative activity against human small cell lung cancer in cell culture and nude mice models via the E2F pathway. PLoS One 5:e10243.
36. Hooper JE, Scott MP (2005). Communicating with Hedgehogs. Nat Rev Mol Cell Biol 6:306-317. (Pubitemid 40516897)
37. Thayer SP, di Magliano MP, Heiser PW, Nielsen CM, Roberts DJ, et al. (2003). Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis. Nature 425:851-856. (Pubitemid 37355945)
38. Berman DM, Karhadkar SS, Maitra A, Montes De Oca R, Gerstenblith MR, et al. (2003). Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumours. Nature 425:846-851. (Pubitemid 37351469)
39. Sicklick JK, Li YX, Jayaraman A, Kannangai R, Qi Y, et al. (2006). Dysregulation of the Hedgehog pathway in human hepatocarcinogenesis. Carcinogenesis 27:748-757.
40. Dormoy V, Danilin S, Lindner V, Thomas L, Rothhut S, et al. (2009). The sonic hedgehog signaling pathway is reactivated in human renal cell carcinoma and plays orchestral role in tumor growth. Mol Cancer 8:123.
41. Varnat F, Duquet A, Malerba M, Zbinden M, Mas C, et al. (2009). Human colon cancer epithelial cells harbour active HEDGEHOG-GLI signaling that is essential for tumour growth, recurrence, metastasis and stem cell survival and expansion. EMBO Mol Med 1:338-351.
42. Fendrich V, Rehm J, Waldmann J, Buchholz M, Christofori G, et al. (2011). Hedgehog inhibition with cyclopamine represses tumor growth and prolongs survival in a transgenic mouse model of islet cell tumors. Ann Surg 253:546-552.
43. Watkins DN, Berman DM, Burkholder SG, Wang B, Beachy PA, et al. (2003). Hedgehog signaling within airway epithelial progenitors and in small-cell lung cancer. Nature 422:313-317. (Pubitemid 36378358)
44. El Khatib M, Kalnytska A, Palagani V, Kossatz U, Manns MP, et al. (2013). Inhibition of Hedgehog signaling attenuates carcinogenesis in vitro and increases tumor necrosis of cholangiocellular carcinomas. Hepatology 57(3):1035-45.
45. Jinawath A, Akiyama Y, Sripa B, Yuasa Y. (2007). Dual blockade of the Hedgehog and ERK1/2 pathways coordinately decreases proliferation and survival of cholangiocarcinoma cells. J Cancer Res Clin Oncol 133: 271-278.
46. Omenetti A, Choi S, Michelotti G, Diehl A. (2011). Hedgehog signaling in the liver. J Hepatol 54(2):366-73.
47. Fingas CD, Bronk SF, Werneburg NW, Mott JL, Guicciardi ME, et al. (2011) Myofibroblast-derived PDGF-BB promotes Hedgehog survival signaling in cholangiocarcinoma cells. Hepatology 54: 2076-2088.
48. Tang L, Tan YX, Jiang BG, Pan YF, Li SX, et al. (2013). The prognostic significance and therapeutic potential of hedgehog signaling in intrahepatic cholangiocellular carcinoma. Clin Cancer Res 15;19(8):2014-24.
49. Zender S, Nickeleit I, Wuestefeld T, Sörensen I, Dauch D, et al. (2013). A critical role for notch signaling in the formation of cholangiocellular carcinomas. Cancer Cell 10;23(6):784-95.
50. Stewart SA, Dykxhoorn DM, Palliser D, Mizuno H, Yu EY, et al. (2003). Lentivirus-delivered stable gene silencing by RNAi in primary cells. RNA 9: 493-501. (Pubitemid 36356735)
51. Chen D, Yang Z, Wang Y, Zhu G, Wang X (2012). Capsaicin induces cycle arrest by inhibiting cyclin-dependent-kinase in bladder carcinoma cells. Int J Urology 19: 662-8.
52. Lin CH, Lu WC, Wang CW, Chan YC, Chen MK (2013). Capsaicin induces cell cycle arrest and apoptosis in human KB cancer cells. BMC Complent Altern Med.
53. Bley K, Boormann G, Mohammad B, McKenzie D, Babbar S (2012). A comprehensive review of the carcinogenesis and anticarcinogenic potential of capsaicin. Toxilogic Pathology 40: 847-873.
54. Jing Y, Han Z, Zhang S, Liu Y, Wei L (2011). Epithelial-Mesenchymal Transition in tumor microenvironment. Cell Biosci 1: 29.
55. Omenetti A, Porrello A, Jung Y, Yang L, Popov Y, et al. (2008). Hedgehog signaling regulates epithelial-mesenchymal transition during biliary fibrosis in rodents and humans. J Clin Invest 118:3331-3342.
56. Araki K, Shimura T, Suzuki H, Tsutsumi S, Wada W, et al. (2011) E/N-cadherin switch mediates cancer progression via TGF-beta-induced epithelial-to-mesenchymal transition in extrahepatic cholangiocarcinoma. Br J Cancer 105: 1885-1893.
57. Yang J, Li TZ, Xu GH, Luo BB, Chen YX et al. (2013). Low-concentration capsaicin promotes colorectal cancer metastasis by triggering ROS production and modulating Akt/mTOR and STAT-3 pathways. Neoplasma 60: 364-72.
58. Bai H, Li H, Zhang W, Matkowskyj KA, Liao J, et al. (2011). Inhibition of chronic pancreatitis and pancreatic intraepithelial neoplasia (PanIN) by capsaicin in LSL-KrasG12D/Pdx1-Cre mice. Carcinogenesis 32: 1689-96.